NECLIFE logo

Nectar Lifesciences Limited Stock Price

NSEI:NECLIFE Community·₹4.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

NECLIFE Share Price Performance

₹0
-34.20 (-100.00%)
₹0
-34.20 (-100.00%)
Price ₹0

NECLIFE Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and good value.

3 Risks
1 Reward

Nectar Lifesciences Limited Key Details

₹16.7b

Revenue

₹13.9b

Cost of Revenue

₹2.8b

Gross Profit

₹4.0b

Other Expenses

-₹1.1b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-5.08
16.89%
-6.82%
64.0%
View Full Analysis

About NECLIFE

Founded
1995
Employees
1786
CEO
Amit Chadah
WebsiteView website
www.neclife.com

Nectar Lifesciences Limited manufactures, distributes, markets and sells pharmaceutical products in India and internationally. The company offers cephalosporins, includes pharmaceutical ingredients and intermediates comprising cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also provides contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company offers menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.

Recent NECLIFE News & Updates

Recent updates

No updates